BACKGROUND

The capacity of skeletal muscles to regenerate relies on Pax7 muscle stem cells (MuSC). While in vitro-amplified MuSC are activated and lose part of their regenerative capacity, in vitro-generated human muscle reserve cells (MuRC) are very similar to quiescent MuSC with properties required for their use in cell-based therapies.

METHODS

In the present study, we investigated the heterogeneity of human MuRC and characterized their molecular signature and metabolic profile.

RESULTS

We observed that Notch signaling is active and essential for the generation of quiescent human Pax7 MuRC in vitro. We also revealed, by immunofluorescence and flow cytometry, two distinct subpopulations of MuRC distinguished by their relative Pax7 expression. After 48 h in differentiation medium (DM), the Pax7 subpopulation represented 35% of the total MuRC pool and this percentage increased to 61% after 96 h in DM. Transcriptomic analysis revealed that Pax7 MuRC were less primed for myogenic differentiation as compared to Pax7 MuRC and displayed a metabolic shift from glycolysis toward fatty acid oxidation. The bioenergetic profile of human MuRC displayed a 1.5-fold decrease in glycolysis, basal respiration and ATP-linked respiration as compared to myoblasts. We also observed that AMPKα1 expression was significantly upregulated in human MuRC that correlated with an increased phosphorylation of acetyl-CoA carboxylase (ACC). Finally, we showed that fatty acid uptake was increased in MuRC as compared to myoblasts, whereas no changes were observed for glucose uptake.

CONCLUSIONS

Overall, these data reveal that the quiescent MuRC pool is heterogeneous for Pax7 with a Pax7 subpopulation being in a deeper quiescent state, less committed to differentiation and displaying a reduced metabolic activity. Altogether, our data suggest that human Pax7 MuRC may constitute an appropriate stem cell source for potential therapeutic applications in skeletal muscle diseases.